EMJ Urology 7 [Suppl 2] . 2019

| View in Fullscreen

In this issue

This review aims to summarise the evidence supporting the use of MFS as a clinical endpoint and the benefit of delaying metastasis in men with high-risk nmCRPC, and to discuss the influence of next-generation imaging on prostate cancer staging.